Federal Circuit Invalidates Acne Treatment Patents

Federal Circuit Invalidates Acne Treatment Patents

WASHINGTON, D.C. - A Delaware federal judge erred in finding a series of acne treatment patents not invalid as obvious, a divided panel of the Federal Circuit U.S. Court of Appeals ruled Dec. 11 (Galderma Laboratories LP et al. v. Tolmar Inc., No. 13-1034, Fed. Cir.).

Find full version on lexis Advance®
Access this news story on lexis.com®